This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Background and Date of Approval

The U.S. FDA-approved Telmisartan + Indapamide for hypertension on July 23, 1998. Telmisartan + Indapamide belongs to the group of medications called antihypertensives.

Mechanism of Action of undefined

Telmisartan works by preventing the action of certain substances that tighten blood vessels (arteries). It improves blood flow and increases the heart's ability to pump blood effectively throughout the body. Indapamide eliminates excess water and electrolytes from the body. Furthermore, it relaxes blood vessels and improves blood flow. They reduce blood pressure and minimize the risk of heart attack, stroke, and edema (fluid retention).

Uses of undefined

Telmisartan + Indapamide It is primarily used for the treatment of hypertension. Hypertension (high blood pressure) is a medical condition in which blood exerts a force on the artery walls (blood vessels), resulting in heart disease, irregular heartbeat, and other problems.

undefined Drug administaration and Dosage available

Take the Telmisartan+ Indapamide as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Warnings, Precautions and Side Effects of undefined


Telmisartan + Indapamide should not be consumed if you are allergic to Telmisartan + Indapamide or any of its ingredients in the medication. Report to your physician if you have kidney or severe liver diseases, heart rhythm problems, vision problems or eye pain, muscle disorders, a low potassium level (hypokalemia), blood pressure, and the number of electrolytes (potassium) in your blood at regular intervals. It is not recommended for pregnant and breastfeeding women.


Notify your doctor if you are pregnant, planning to get pregnant, or think you may be pregnant or breastfeeding. The dosage adjustment is needed for patients with kidney problems. Telmisartan+ Indapamide should be used cautiously in patients with liver impairment or severe liver disease. Notify your doctor about your pre-existing liver condition. Consult your doctor for advice.

Side Effects

The most common side effects of Telmisartan + Indapamide are sleepiness, trouble concentrating, dry mouth, dizziness, increase in appetite, drowsiness, and headache. Serious side effects while taking Telmisartan + Indapamide are angioedema or urticaria (swelling of skin and mucosa), severe skin reaction (intense skin rash, itching, blistering, swelling of skin), kidney disease, abnormal hepatic function.

Word Of Advice

It is suggested to monitor your blood pressure regularly to prevent hypotension. Get up slowly while rising from a lying or sitting position, as Telmisartan+ Indapamide may cause dizziness. It is advised to monitor electrolyte levels, as this medication may cause electrolyte fluctuations. This medicine should be used cautiously in patients with kidney impairment or severe kidney disease. Consult your doctor for advice.

Frequently Asked Question


  1. MSN Laboratories Europe Limited, Electronic Medicines Compendium (EMC), [Revised on September 2022] [Accessed on 1st June 2023], *pil.13404.pdf (
  2. Pfizer, US Food and Drug Administration; [Revised on May 2018] [Accessed on 1st June 2023],,022488s013lbl.pdf
  3. Sheena Derry et al; Telmisartan + Indapamide for neuropathic pain in adults; [Revised on 2019] [Accessed on 1st June 2023],
  4. Cross AL; Viswanath O; Sherman AI; Telmisartan + Indapamide; NCBI Bookshelf; [Revised on 2021] [Accessed on 1st June 2023],


The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.